Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

MINNEAPOLIS - Jamf (NASDAQ: NASDAQ:JAMF), a $1.89 billion market cap company specializing in Apple (NASDAQ:AAPL) device management and security, has announced that its Jamf Pro and Jamf School ...

Ethereum's Holesky testnet achieved finality after a two-week disruption following the activation of the Pectra upgrade on Feb. 24, 2025.